• About Us
    • About Laurus
    • Research & Development
    • Leadership
    • Strengths & Strategy
    • Corporate Sustainability
  • Business Units
    • Generics API
    • Generics FDF
    • Synthesis
    • Biotechnology
    • Facilities
  • Investors
  • Media
  • Contact
    • Laurus Synthesis
    • Laurus Generics GMBH
    • Laurus Generics Inc
    • Laurus Bio
    • India Business
  • Home
  • About Us
    • About Laurus
    • Research & Development
    • Leadership
    • Strengths & Strategy
    • Corporate Sustainability
  • Business Units
    • Generics API
    • Generics FDF
    • Synthesis
    • Biotechnology
    • Facilities
  • Investors
    • Financials
    • Disclosures
    • Shareholding
    • Corporate Governance
  • Media
  • Careers
  • Contact
  • Laurus Synthesis
  • Laurus Generics Gmbh
  • Laurus Genrics Inc
  • Laurus Bio
  • India Business
INVESTORS / Shareholding
Information on the quarterly-wise shareholding pattern

Shareholding Pattern Q1 2022-23

Shareholding Pattern Q1 2022-23

Shareholding Pattern Q2 2022-23

Shareholding Pattern Q3 2022-23

Shareholding Pattern Q4 2022-23

Shareholding Pattern Q1 2021-22

Shareholding Pattern Q2 2021-22

Shareholding Pattern Q3 2021-22

Shareholding Pattern Q4 2021-22

Shareholding Pattern Q1 2020-21

Shareholding Pattern Sep 30 2020

Shareholding Pattern Q3 Dec 31 2020

Shareholding Pattern Q4 2021

Shareholding Pattern Q1 2019-20

Shareholding Pattern Q2 FY 2020

Shareholding Pattern Q3 2019-20

Shareholding Pattern Q4 2019-20

    Shareholding Pattern Q1 2018-19

    Shareholding Pattern Q2 2018-19

    Shareholding Pattern Q3 2018-19

    Shareholding Pattern Q4 2018-19

Shareholding Pattern Q1 2017-18

Shareholding Pattern Q2 2017-18

Shareholding Pattern Q3 2017-18

Shareholding Pattern Q4 2017-18

Q3-Shareholding Pattern

Shareholding Pattern Q4 2016-17

Unclaimed Dividend Data as on March 31, 2023


FINANCIAL RESULTS FY2023-24

For more information write to investorrelations@lauruslabs.com

Find out more about us
Strengths & Strategy

We are building on our strengths to further extend our product portfolio and target fast-growing segments.

Research & Development

As a science-led pharmaceutical company, we invest in cutting-edge research to develop new cures for challenging diseases.

Corporate Sustainability

As a responsible corporate citizen, we will conduct our business with complete respect for the environment and community.

    ABOUT US
  • About Laurus
  • Research & Development
  • Leadership Team
  • Strengths & Strategy
  • Corporate Sustainability
    BUSINESS UNITS
  • Generics API
  • Generics FDF
  • Synthesis
  • Facilities
  • INVESTORS
    CONNECT
  • Media
  • Careers
  • Locations
    POLICIES
  • Cookies Policy
  • Privacy Policy